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Abstract
Background Aim of this study was to evaluate and compare perioperative outcomes of transperitoneal (TP) and retroperi-
toneal (TR) approaches in a multi-institutional cohort of minimally invasive partial nephrectomy (MI-PN).
Material and methods All consecutive patients undergone MI-PN for clinical T1 renal tumors at 26 Italian centers (RECORd2 
project) between 01/2013 and 12/2016 were evaluated, collecting the pre-, intra-, and postoperative data. The patients were 
then stratified according to the surgical approach, TP or RP. A 1:1 propensity score (PS) matching was performed to obtain 
homogeneous cohorts, considering the age, gender, baseline eGFR, surgical indication, clinical diameter, and PADUA score.
Results 1669 patients treated with MI-PN were included in the study, 1256 and 413 undergoing TP and RP, respectively. 
After 1:1 PS matching according to the surgical access, 413 patients were selected from TP group to be compared with the 
413 RP patients. Concerning intraoperative variables, no differences were found between the two groups in terms of surgical 
approach (lap/robot), extirpative technique (enucleation vs standard PN), hilar clamping, and ischemia time. Conversely, 
the TP group recorded a shorter median operative time in comparison with the RP group (115 vs 150 min), with a higher 
occurrence of intraoperative overall, 21 (5.0%) vs 9 (2.1%); p = 0.03, and surgical complications, 18 (4.3%) vs 7 (1.7%); 
p = 0.04. Concerning postoperative variables, the two groups resulted comparable in terms of complications, positive surgi-
cal margins and renal function, even if the RP group recorded a shorter median drainage duration and hospital length of stay 
(3 vs 2 for both variables), p < 0.0001.
Conclusions The results of this study suggest that both TP and RP are feasible approaches when performing MI-PN, irre-
spectively from tumor location or surgical complexity. Notwithstanding longer operative times, RP seems to have a slighter 
intraoperative complication rate with earlier postoperative recovery when compared with TP.
Keywords Renal cell carcinoma · Minimally invasive partial nephrectomy · Transperitoneal · Retroperitoneal · Surgical 
approach
The incidental detection of renal masses increased over the 
last decades due to the expanding use of imaging diagnosis 
performed for other reasons [1]. Alongside with this occur-
rence, kidney surgery has undergone both theoretical and 
technical developments [2, 3]. Firstly, the indication for par-
tial nephrectomy (PN) in elective cases has been expanded 
widely, being well demonstrated the advantages of partial 
over radical surgery in T1 tumors in terms of functional 
preservation with similar oncological safety [4–6]. On the 
other hand, the technological improvements of the last 30 
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years paved the way for the gradually increased employment 
of minimally invasive approaches, first with the advent of 
laparoscopy and then with robotics, progressively minimiz-
ing the impact and invasiveness of surgical procedures [7–9].
The surgical access, either trans or retroperitoneal (TP 
or RP), plays a key role in kidney surgery, since it mean-
ingfully influences the comfort of the procedure as well as 
perioperative outcomes [10, 11]. To date, the choice between 
TP or RP access has been traditionally influenced by tumor- 
(location and surgical complexity) and patient-related fea-
tures (previous abdominal surgery, presence of abundant 
abdominal fat) [12, 13]. However, in the last few years, the 
ongoing improvements of computer-enhanced technology 
have provided the necessary means for surgeons to assimi-
late minimally invasive surgical options into their everyday 
surgical practice and overcome the surgical limitation related 
to conventional surgery. In this light, robotic surgery made 
easier to perform even complex surgical procedures with 
both accesses thanks to an improved ergonomic position for 
the surgeon, three-dimensional vision of the operating field 
and augmented maneuverability of the instruments due the 
EndoWrist® technology.[14].
Nevertheless, to date, the final choice between TP or RP 
approach still remains strictly influenced by the surgeon 
preference and the advantages of different surgical access 
during laparoscopic or robotic PN has not been clearly high-
lighted yet [15, 16].
To fill this gap, the aim of the current study was to evalu-
ate and compare the perioperative outcomes in patients 
treated with TP and RP minimally invasive PN for clini-
cal T1 renal tumors in a large multi-institutional study (The 
RECORD 2 project).
Materials and methods
The Italian REgistry of COnservative and Radical Sur-
gery for cortical renal tumor Disease (RECORD 2 Project) 
is a prospective observational multicenter project pro-
moted by the Italian Society of Urology (SIU). This study 
was approved by the local ethics committee, and written 
informed consent was collected for all the patients. Overall 
4325 consecutive patients undergone renal surgery for cor-
tical renal tumors at 26 urological Italian centers between 
January 1, 2013, and December 31, 2016, were included. For 
each patient, anthropometric and preoperative data, imag-
ing, indications and co-morbidities, intraoperative data, 
postoperative data, histological analysis, follow-up were 
collected in an e-form central database to limit missing or 
wrong data inputs. Comorbidity status was evaluated by 
Charlson comorbidity index (CCI), physical status (PS) by 
the American Society of Anesthesiologists (ASA) classifi-
cation system. Surgical indications were defined as elective 
(unilateral lesion with healthy contralateral kidney), relative 
(presence of diabetes, hypertension or lithiasis that could 
potentially affect kidney function in the future) and absolute 
(bilateral tumors, multiple tumors, moderate to severe CKD 
or tumors involving an anatomically or functionally solitary 
kidney). Center experience was evaluated as number of PN/
year and PN/RN ratio per year. Surgical approach and type 
of resection were chosen according to surgeons’ preference 
and centers availability.
For the purpose of this study, only patients undergone 
minimally invasive PN (mi-PN) for clinical T1 renal tumors 
were included at a first stage. Therefore, 1712 patients 
treated with radical nephrectomy and 886 patients treated 
with open PN, 47 patients with cT ≥ 2 and 11 patients 
with missing data undergone minimally invasive PN were 
excluded and only patients undergone minimally invasive TP 
(n = 1256) and RP (n = 413) from 21 centers were included.
Statistical analysis
A propensity score matching was performed on the selected 
cohort to settle on two cohorts of patients undergone TP 
and RP MI-PN with comparable preoperative clinical fea-
tures [17]. The matching was carried out with a 1:1 ratio 
with respect to the surgical access (413 TP vs 413 RP 
mi-PN) with a C statistic of 0.67 adjusting for the variables: 
age, gender, baseline eGFR, surgical indication, clinical 
diameter, ECOG and ASA PS scores, tumor location and 
PADUA score. The difference between the two groups is 
plotted in Supplementary Fig. 1. The Student t-test and the 
Mann–Whitney-U test were used to compare continuous 
to categorical variables and the Pearson’s Chi-square test 
was used to compare two categorical variables. Statistical 
significance was set at p < 0.05. All reported p values were 
two-sided. Analyses were carried out with RStudio graphi-
cal interface v.0.98 for R software environment v.3.0.2, 
using the packages MatchIt, rms and histbackback, and with 
STATA v.14.1 (StataCorp LP, College Station, TX).
Results
Patients and tumors features
Preoperative tumor and patient features of the selected 
cohorts after propensity score matching are reported in 
Table 1. After propensity score matching, all the variables 
were comparable between the two groups. In detail, patients 
included in the TP and RP cohorts were males in 65.6% and 
61.8% of the cases (p = 0.67), respectively. Patients had a 
median (interquartile range [IQR]) age of 64.8 (56.2–72.4) 
and 64.6 (55.9–72.3) years (p = 0.71), and a median (IQR) 
BMI of 25.9 (23.9–28.7) and 25.8 (23.7–28.4) in the TP 
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and RP group (p = 0.95), respectively. The CCI score and 
the ASA PS score were 1 (0–2) and 2 (2–3) for both groups. 
Patients had relative and absolute indication for surgery in 
20.8% and 3.7% of TP group versus 24.9% and 5.5% of the 
RP group (p = 0.24).
A clinical T1a (cT1a) and cT1b stage were reported in 
79.9% and 20.1% of TP while in 80.1% and 19.9% of the 
RP patients (p = 0.82), respectively. The median (IQR) 
PADUA score was 7 (7–8) for both groups (p = 0.69), with 
PADUA ≥ 10 registered in 3.4% of TP and 3.9% of RP 
patients, respectively. The propensity score matching evened 
the differences also in terms of tumor location: the percent-
age of tumors located on the lateral margin, medial margin, 
anterior face and posterior face were 33.7% vs 34.6%, 11.8% 
vs 11.3%, 9.9% vs 9.0% and 44.3% vs 45.0% for TP and RP 
groups, not considering the surgical access. At baseline the 
median (IQR) values of preoperative creatinine were 0.9 mg/
dl (0.8–1) and 0.9 mg/dl (0.8–1.1), with an eGFR of 85.1 ml/
min/m2 (70.3–96.6) and 82.8 ml/min/m2 (66.8–99.5) for TP 
and RP cohort, respectively.
Surgical features
The surgical features of the two cohorts after propensity 
score matching are summarized in Table 2.
Overall, 12/21 (57.1%) and 6/21 (28.6%) centers per-
formed > 30 and > 50 mi-PNs per year, respectively. An 
overview of the distribution of surgical accesses for each 
center is shown in Fig. 1. Patients undergone RP were 
treated in centers performing a median (IQR) of 71 (44–84) 
PNs/year, while the matched patients undergone TP under-
went surgery in centers with a median of 56 (35–79) PN/year 
(p < 0.0001). Specifically, in the RP cohort, 331 (80.2%) and 
315 (76.3%) patients were treated in centers performing > 30 
and > 50 PNs/year, while of the TP cohort only 313 (75.8%) 
and 256 (62.0%) patients underwent surgery in centers per-
forming > 30 and > 50 PNs/year (p < 0.001). Moreover, the 
median PN/RN ratio was 74.0% (66.6–87.9%) and 66.6% 
(50.6–78%) for RP and TP groups, respectively (p < 0.001).
Laparoscopic PN (LPN) and robot-assisted PN (RAPN) 
were planned in 281 (68.0%) and 132 (32.0%) cases with TP 
access versus 279 (67.5%) and 134 (33.5%) cases with RP 
access, respectively (p = 0.67).
Considering the hilar clamping approach, in 47.9% of 
the TP and 51.6% of the RP surgeries, renal pedicle was not 
clamped. When hilar clamping was performed, the median 
(IQR) ischemia time was 19 (14–24) and 20 (15–25) min 
for the two groups (p = 0.14). Simple enucleation was per-
formed in 41.9% of the TP and 40.9% of the RP, respectively 
(p = 0.77).
Median EBL for the two groups were similar (100 ml 
and 150 ml, p = 0.10). Conversely, the RP group had shorter 
median intraoperative (skin to skin) time compared the TP 
group (115 vs 150 min, p < 0.0001).
The intraoperative overall complications rate (5% vs 
2.1%, p = 0.03) and the intraoperative surgical complications 
rate (4.3% vs 1.7%, p = 0.04) were higher in the TP com-
pared to the RP group. Conversely, no differences between 




the groups were recorded in terms of intraoperative medical 
complications (0.7% vs 0.5%, p = 0.64).
Postoperative and functional features
Postoperative and functional outcomes of the two cohorts 
after propensity score matching are shown in Table 3. No dif-
ferences were found in terms of postoperative complication 
Table 1  Comparison of the 
preoperative characteristics 
of 413 patients treated with 
retroperitoneal minimally 
invasive partial nephrectomy 
with selected matched 
413 patients treated with 
transperitoneal minimally 
invasive partial nephrectomy 
for renal tumors within the 
RECORD 2 project
RECORD 2 project—preoperative tumor and 
patient data






 Male 271 65.6% 280 67.8% 0.67
 Female 142 34.4% 133 32.2%
Age (years), median IQR 64.8 56.2–72.4 64.6 55.9–72.3 0.71
BMI, median IQR 25.9 23.9–28.7 25.8 23.7–28.4 0.95
ECOG score, n. %
 0 311 75.3% 315 76.3% 0.69
 ≥ 1 92 24.6% 98 23.7%
CCI score, median IQR 1 0–2 1 0–2 0.71
ASA PS score, median IQR 2 2–3 2 2–3 0.82
Indication, n. %
 Elective 312 75.5% 287 69.6% 0.24
 Relative 86 20.8% 103 24.9%
 Absolute 19 3.7% 23 5.5%
Clinical T, n. %
 T1a 330 79.9% 331 80.1% 0.82
 T1b 83 20.1% 82 19.9%
Tumor side, n. %
 Right 202 48.9% 194 47.0% 0.93
 Left 211 51.1% 219 53.0%
Clinical diameter, median IQR 3.2 1.9–4.6 3.1 1.8–4.5 0.63
Tumor site, n. %
 Mesorenal 271 65.6% 278 67.3% 0.18
 Polar 142 34.4% 135 32.7%
Tumor growth pattern, n. %
 ≥ 50% Exophytic 229 55.4% 240 58.1% 0.41
 < 50% Exophytic 160 38.7% 147 35.6%
 Entirely endophytic 24 5.8% 26 6.3%
PADUA Score, median IQR 7.0 7.0–8.0 7.0 7.0–8.0 0.69
PADUA complexity group, n. %
 Low (6–7) 244 59.1% 251 60.8% 0.78
 Medium (8–9) 155 37.5% 146 35.4%
 High (≥ 10) 14 3.4% 16 3.9%
Tumor localization, n. %
 Lateral margin 139 33.7% 143 34.6% 0.26
 Medial margin 49 11.8% 46 11.3%
 Anterior face 41 9.9% 37 9.0%
 Posterior face 183 44.3% 187 45.0%
 Peri-hilar 1 0.2% 0 0%
Preoperative hemoglobin, mean SD 14.5 13.4–15.3 14.2 13.3–15.2 0.83
Preoperative creatinine (mg/dl), mean SD 0.9 0.80–1.00 0.9 0.80–1.10 0.19
Preoperative eGFR, median IQR 85.1 70.3–96.6 82.8 66.8–99.5 0.67
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rates between the two groups, considering both surgical and 
medical ones (7% vs 6.1% and 3.9% vs 3.4% in TP and RP 
group, p = 0.57 and p = 0.48, respectively). Stratifying the 
surgical complications according to Clavien-Dindo classifi-
cation [20], 4.1% and 3.4% Clavien > 2 complications were 
recorded in TP and RP groups, respectively (p = 0.57).
The median (IQR) days of drain was longer in the TP 
compared to the RP group (3 (2–4) vs 2 (1–2), p < 0.0001) as 
well as time to canalization (3 (2–5) vs 2 (1–3), p < 0.0001) 
and hospital length of stay [3 (3–4) vs 2 (2–3) days, 
p < 0.0001].
Conversely, no differences were recorded between the 
groups considering the percentage of malignant tumors and 
the positive surgical margins rate (74.6% vs 75.1% and 5.1% 
vs 5.6% for TP and RP, respectively).
Regarding the functional outcomes, the two groups 
resulted comparable in terms of early postoperative median 
serum creatinine (1  mg/dl, p = 0.18) and eGFR levels 
(76 ml/min/m2 and 76 ml/min/m2 for TP and RP, p = 0.08). 
Moreover, when considering the median variation of eGFR 
between the baseline value and each different evaluation 
considered during the follow-up (3rd POD, 6th month, 12th 
month, 24th month), no significant differences between TP 
and RP mi-PN were recorded.
Discussion
Open PN has traditionally represented the gold standard 
treatment for the surgical management of localized renal 
masses amenable to conservative surgery [1, 5]. However, 
in the last decades minimally invasive approaches in PN 
have been confirmed as safe, feasible, and effective alterna-
tives to open surgery with several proven advantages such as 
shorter postoperative pain and, thus, hospital stay and lower 
complication rate [18–20].
Table 2  Comparison of the centers data and the intraoperative char-
acteristics of 413 patients treated with retroperitoneal minimally inva-
sive partial nephrectomy with selected matched 413 patients treated 
with transperitoneal minimally invasive partial nephrectomy for renal 
tumors within the RECORD 2 project
RECORD 2 project—intraoperative center and surgical data Surgical access p value
Transpertioneal (n = 413) Retroperitoneal (n = 413)
PN/RN ratio, median (IQR) 66.6% (50.6–78%) 74.0% (66.6–87.9%)  < 0.0001
Number of PN/year of the center of treatment, median (IQR) 56 (35–79) 71 (44–84)  < 0.0001
Center volume, n (%)
 > 30 PN/year 313 (75.8%) 331 (80.1%) 0.001
 > 50 PN/year 256 (62.0%) 315 (76.3%) 0.001
Surgical approach
 Laparoscopic 281 (68.0%) 279 (67.5%) 0.67
 Robotic 132 (32.0%) 134 (33.5%)
Technique, n (%)
 Enucleation 173 (41.9%) 169 (40.9%) 0.77
 Standard PN 240 (58.1%) 244 (59.1%)
Hilar clamping, n (%)
 Not performed 198 (47.9%) 213 (51.6%) 0.29
 Performed 215 (52.1%) 200 (48.4%)
Ischemia time(min), median (IQR) 19 (14–24) 20 (15–25) 0.14
EBL (cc), median (IQR) 100 (100–200) 150 (100–143) 0.10
Extended peritoneum opening, n (%) 32 (7.7%) – –
Intraoperative time, median (IQR) 115 (96–130) 150 (120–180)  < 0.0001
Intraoperative overall complications, n (%) 21 (5.0%) 9 (2.1%) 0.03
Intraoperative surgical complications, n (%) 18 (4.3%) 7 (1.7%) 0.04
 Vascular lesion, n (%) 9 (2.1%) 4 (0.8%) –
 Spleen injury, n (%) 2 (0.4%) – –
 Conversion to open procedure, n (%) 4 (0,8%) 2 (0.4%) –
 Bleeding from renal resection bed, n (%) 3 (0.2%) 1 (0.2%) –
Intraoperative medical complications, n (%) 3 (0.7%) 2 (0.5%) 0.64
 Miocardial infarction, n (%) 2 (0.4%) 1 (0.2%) –
 Arrytmias, n (%) 1 (0.2%) 1 (0.2%) –
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The progressively greater ability of surgeons with mini-
mally invasive approaches led to a significantly rising 
adoption of RP access [10–12, 15]. The RP access can be 
extremely challenging from a surgical standpoint due to (1) 
the limited working space which makes the development 
of RP space a meticulous and crucial step and (2) the pos-
sibility of breaching the peritoneum (3) a slightly harder 
identification and isolation of the anatomical landmarks. 
However, the RP access in mi-PN allows to gain a prompt 
and direct access to renal hilum to reduce operative time 
and the risk of renal pedicle injury during its isolation [15]. 
Furthermore, the constraint of the procedure in the retrop-
eritoneum allows to minimize the postoperative ileus and 
even more significantly reduce the postoperative distress and 
facilitate an early discharge.
In this study, a large, nation-based and prospectively 
compiled contemporary dataset was analyzed to compare 
the perioperative and medium-term functional outcomes 
in patients with cT1 renal tumors and comparable char-
acteristics at baseline, through a propensity score match-
ing, and undergone TP versus RP mi-PN [21]. We found 
that RP mi-PN was more significantly performed in cent-
ers with higher caseload and a higher attitude to perform 
conservative surgery. Patients undergone RP mi-PN had a 
significantly lower rate of overall and surgical intraoperative 
complications, a lower time of drain maintenance and post-
operative hospital stay compared to those patients treated 
with TP mi-PN. Conversely, intraoperative time was sig-
nificantly lower in TP mi-PN procedures compared to their 
counterparts. Furthermore, our results showed comparable 
outcomes between RP and TP mi-PN in terms of pedicle 
clamping and ischemia time, postoperative complications, 
surgical margins, and short- and medium-term renal func-
tion recovery.
Table 3  Comparison of the postoperative outcomes of 413 patients 
treated with retroperitoneal minimally invasive partial nephrectomy 
with selected matched 413 patients treated with transperitoneal 
minimally invasive partial nephrectomy for renal tumors within the 
RECORD 2 project
RECORD 2 project—report of early postoperative and functional follow-up 
outcomes
Surgical access p value
Transpertioneal (n = 413) Retroperitoneal (n = 413)
Surgical postoperative complications, n (%) 29 (7%) 25 (6.1%) 0.57
 Surgical clavien 2 postop complications, n (%) 12 (2.9%) 11 (2.7%)
 Surgical clavien 3a, postop complications, n (%) 11 (2.7%) 10 (2.4%)
 Surgical clavien 3b, postop complications, n (%) 3 (0.7%) 4 (1%)
 Surgical clavien 4a, postop complications, n (%) 3 (0.7%) 0
 Transfusions, n (%) 21 (5.1%) 15 (3.6%)
 Deep vein thrombosis, n (%) 1 (0.2%) 0
 Superselective embolization, n (%) 8 (2.0%) 7 (1.7%)
 Urinary fistula treated without stenting, n (%) 4 (0.8%) 4 (0.8%)
 Urinary fistula treated with stenting or nephrostomy tube, n (%) 2 (0.4%) 1 (0.2%)
Medical postoperative complications, n (%) 16 (3.9%) 14 (3.4%) 0.48
 Respiratory complications, n (%) 8 (2.0%) 8 (2.0%)
 Cardiologic complications, n (%) 7 (1.7%) 5 (1.2%)
 Acute pulmonary embolism, n (%) 1 (0.2%) 1 (0.2%)
Drainage duration (days), median (IQR) 3 (2–4) 2 (1–2)  < 0.0001
Time to bowel canalization, median (IQR) 3 (2–5) 2 (1–3)  < 0.0001
Hospital length of stay (days), median (IQR) 3 (3–4) 2 (2–3)  < 0.0001
Malignant tumors, n (%) 308 (74.6%) 310 (75.1%) 0.82
Positive surgical margins, n (%) 21 (5.1%) 23 (5.6%) 0.73
Preoperative—1st postoperative day Δ hemoglobin (mg/dL), median (IQR) 1.7 (1.1–3.0) 1.5 (0.9–2.7) 0.48
Preoperative—3rd postoperative day Δ hemoglobin (mg/dL), median (IQR) 2.2 (1.4–3.1) 1.8 (1.0–2.9) 0.25
1st POD creatinine (mg/dl), median (IQR) 1.0 (0.8–1.2) 1.0 (0.8–1.3) 0.18
1st POD eGFR, median (IQR) 76 (61.0–89.0) 73 (57.2–89.0) 0.08
Preoperative—1st POD Δ eGFR, median (IQR) 10.3 (0.0–20.8) 10.4 (0.0–22.5) 0.69
Preoperative—3rd POD Δ eGFR, median (IQR) 10.1 (0.0–20.1) 9.0 (0.0–20.7) 0.53
Preoperative—6th month Δ eGFR, median (IQR) 8.7 (0.3–15.9) 8.8 (0.4–15.0) 0.65
Preoperative—12th month Δ eGFR, median (IQR) 9.2 (4.1–21.5) 9.3 (3.4–20.8) 0.67
Preoperative—24th month Δ eGFR, median (IQR) 9.6 (4.4–20.5) 9.8 (4.5–20.0) 0.68
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Our study suggests that both accesses, either TP or RP, 
are generally feasible and allow comparable perioperative 
outcomes. In the last decade, many authors faced up to the 
question whether TP or RP approach is better in performing 
PN, especially with the diffusion of laparoscopic and robotic 
approaches. However, no definitive conclusions have been 
drawn and this seems to still remain a never-ending issue 
[10–13, 15].
One possible explanation could be that surgical approach 
is still mainly influenced by the surgeon’s preference [22, 
23]. In fact, even if the RP approach is burdened by the 
smaller working space and harder instruments handling, 
especially in conventional laparoscopy, many surgeons 
are more comfortable with such approach rather than TP 
in treating posterior tumors [22]. Conversely, some others 
underline the overcoming of these limitations with robotic 
technology, which augmented the surgeon’s abilities to work 
in a small confined space [24, 25]. Moreover, even if the 
RP approach requires a strong knowledge of untraditional 
anatomic landmarks, it offers several advantages thanks to 
the direct access to the renal pedicle and avoidance of the 
bowel mobilization.
Another paramount issue is represented by the localiza-
tion of renal tumor. Indeed, tumors localized in the posterior 
face or in the lateral margin or lower pole of the kidney can 
be easily approached with a RP access. Conversely, when a 
TP access is preferred, a prolonged and laborious, extensive 
isolation of kidney from adherent perinephric fat could be 
necessary. Tumors of the inferior pole can be easily managed 
with either TP or RP PN in most of the cases. Contrarily, 
some cases of renal tumors located on the anterior face of 
the kidney can be extremely challenging with a RP access, 
up to become extremely risky or almost impossible to man-
age if these lesions are close to the renal hilum.
In our study a propensity score matching was performed 
to select those cases with comparable patients’ and tumor’s 
characteristics. The number of patients treated with RP 
mi-PN for anterior tumors were low (37 cases, 9%), while 
no case of peri-hilar tumor treated with RP mi-PN was 
reported. This introduces a selection bias and, again, it is 
mainly related to the surgeon’s belief of an easier control 
over tumor resection and anatomical landmarks using a TP 
access. Despite the conclusions of this study cannot be gen-
eralized to all the types of renal tumors, to date, no rand-
omized trials comparing TP and RP mi-PN are available. 
The current evidence come from both prospective and retro-
spective observational studies, single and multi-institutional 
matched pair cohorts and few review and meta-analyses 
[10–13, 15, 24].
Considered together, the results of the different studies 
are inconclusive, being affected by confounding factors 
and biases in the comparison of the cohorts of patients. For 
example, some studies considered different sample sizes, 
different preoperative patient- and tumor-related features 
or single centers experiences [26]. Moreover, in order to 
avoid potential limitations, other authors focused their atten-
tion only on specific surgical approaches, like laparoscopy 
or robotic surgery or on specific tumor features, like pos-
terior or complex cases [27, 28]. In a recently published 
systematic review and meta-analysis comparing the RP and 
TP approaches for posteriorly located tumors treated with 
RAPN, Mclean et al. found no differences in terms of perio-
perative outcomes except for a lower operative time in RP 
PN [29]. They concluded that the most suitable approach 
for index patients’ undergoing RAPN depends on surgeon 
expertise and familiarity with technique, considering the 
patient characteristics using a risk-stratified model.
Similar results were found by Xia et al. [30]. In their 
meta-analysis, they compared the perioperative outcomes 
of TP vs RP RAPN and showed no significant difference in 
terms of complication rate, conversion rate, WIT, EBL, and 
PSM rate. Only OT resulted marginally shorter in RP vs TP 
RAPN (p = 0.05, WMD: 28.03; 95% CI 0.41–55.65). Other 
two meta-analyses comparing TP and RP LPN, including 
7 and 8 studies respectively, showed that RP LPN had a 
shorter OT and hospital stay compared with TP RAPN [10, 
11]. However, many of these studies concluded that RCTs 
and high-quality observational cohort studies with large 
sample size are needed to confirm their findings.
In this study, a large heterogeneous multi-institutional 
population was analyzed to be as much as possible repre-
sentative of the real scenario and to reduce the biases related 
to single centers’ or single surgeons’ settings. A main limita-
tion of this study was the absence of the assessment of each 
surgeon experience. Notwithstanding with these limitations, 
our results suggest that center experience could be identi-
fied as a main driver of the choice of the surgical access 
in mi-PN. In fact, RP access was more frequent in centers 
performing a higher number of PN/year and with a higher 
PN/RN ratio per year compared to the TP group (56 vs 71 
and 66.6% vs 74.0%, p < 0.0001). These two surrogates can 
be representative of the experience of the surgeons within 
a center.
Concerning intraoperative variables, no differences were 
found in terms of EBL or ischemia time, confirming results 
also reported by other Institutions [12, 30]. Contrarily from 
other available studies [16, 24], we evaluated other surgical 
variables potentially influenced by the surgical approach, 
such as the renal pedicle management and the resection tech-
nique. No significant differences between TP and RP PN 
emerged in terms of clampless procedures (47.9% vs 51.6%) 
and simple-enucleation rate (41.9% vs 40.9%).
Compared to most of the literature studies [13], we 
found a shorter median operative time in TP group (115 
vs 150 min, p < 0.0001). This result could be explained 
considering that the RP group is composed also by robotic 
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procedures where the operative time was longer compared 
to laparoscopic RP PN. In fact, in the robotic approach, the 
creation of the virtual retroperitoneal space is performed 
laparoscopically to create a working space for robotic tro-
cars: this could determine an increase of the overall opera-
tive time.
RP approach was associated to a slightly but statistically 
significant lower overall and surgical intraoperative com-
plication rates (5% vs 2.1% and 4.3% vs 1.7%, p = 0.03 and 
p = 0.04, respectively). These evidences can be explained 
considering the advantages offered by RP approach in iden-
tifying easily the renal pedicle and avoiding direct contact 
with the intraperitoneal organs. In fact, stratifying the surgi-
cal intraoperative complications, higher number of vascular 
lesions and spleen injury were recorded in TP group (9 vs 4 
and 2 vs 0, respectively).
Focusing on postoperative outcomes, our findings are 
consistent with most of the current studies on this topic [10, 
11, 15, 24]. No differences were recorded in terms of postop-
erative complications, even stratifying according to Clavien-
Dindo classification, as well as the PSM rate and functional 
outcomes. Patients managed with a RP access showed a 
shorter postoperative recovery, with and earlier drainage 
removal and discharge compared to those treated with TP 
PN. Similar results, explainable considering a smaller fluids 
drainage and a faster canalization in case of RP, were found 
in both pure laparoscopic and robotic case series [10, 15].
To the best of our knowledge this is the largest matched 
pair multi-institutional study comparing TP and RP in 
MI-PN setting. The strength of our results is to highlight 
the feasibility of both approaches, offering similar intra- and 
postoperative results. Indeed, this highlights that, if the sur-
geon is confident using either the RP or the TP access, he 
can modulate the choice more consciously, considering all 
the details of each single case. Notwithstanding its strengths, 
the study is not devoid of limitations. First, the design of 
the study was not randomized, and the access of each case 
was determined by surgeon choice and attitude. Even if the 
matching minimizes the potential biases related to the com-
parison of different populations, a selection bias related to 
the lower rate of anterior and peri-hilar renal tumors in the 
RP group could not be corrected. Thus, definitive conclu-
sions on which surgical access should be preferred basing 
on tumor nephrometric characteristics cannot be drawn. Sur-
geon experience was not evaluated prospectively and for this 
reason it could not be added as parameter for the matching 
balance. On the other side, all the intraoperative characteris-
tics, such as center volume, surgical approach and clamping, 
were not balanced a priori to provide a comprehensive repre-
sentation of the surgical management of cases according to 
the baseline characteristics. Moreover, no detailed long-term 
functional data are available and postoperative oncological 
outcomes were not evaluated.
Conclusions
The results of this study suggest that both TP and RP are fea-
sible approaches when performing MI-PN for cT1 tumors. 
Notwithstanding longer operative times, RP seems to have 
a slighter intraoperative complication rate with earlier 
postoperative recovery when compared with TP. Anyway, 
surgeons’ preference and experience remain the tips of the 
balance in the decision towards the surgical access while 
performing a MI-PN.
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